Literature DB >> 8010552

Hyperthermia in psychostimulant overdose.

C W Callaway1, R F Clark.   

Abstract

Psychostimulant drugs such as amphetamines, amphetamine derivatives, and cocaine produce a variety of potentially lethal effects, and an understanding of these toxic effects is important for emergency physicians. While some effects of psychostimulant poisonings such as cardiovascular compromise and seizures have been discussed extensively, other metabolic derangements such as hyperthermia are less well characterized. In fact, hyperthermia is a common feature of severe-to-lethal poisonings and may be the primary mode of demise in some patients. Animal studies confirm that drug-induced hyperthermia alone can be lethal in some species, although other toxic effects may predominate at different drug doses or rates of administration. In non-lethal poisonings, hyperthermia can produce rhabdomyolysis, leading to further morbidity. Clinical reports and animal studies indicate that hyperthermia is a primary effect of psychostimulant drugs and can occur independently of seizures or increased motor activity. Furthermore, activation of particular dopamine receptors in the central nervous system appears to mediate psychostimulant-induced hyperthermia. The literature suggests cooling and tranquilization of psychostimulant-poisoned patients after cardiovascular stabilization. Paralysis and mechanical ventilation may be required. The involvement of dopamine receptor activation in psychostimulant toxicity suggests that dopamine-blocking neuroleptic drugs may be a useful adjunct to current treatment regimens. However, further studies are required to assess this approach. In summary, hyperthermia is a potentially lethal but treatable manifestation of severe psychostimulant poisoning.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8010552     DOI: 10.1016/s0196-0644(94)70165-2

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  20 in total

1.  Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats.

Authors:  Marley D Kass; Xiangqian Liu; Michael Vigorito; Linda Chang; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-06-09       Impact factor: 4.147

2.  A risk assessment based approach to the management of acute poisoning.

Authors:  F F S Daly; M Little; L Murray
Journal:  Emerg Med J       Date:  2006-05       Impact factor: 2.740

3.  Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats.

Authors:  Alessandra Milesi-Hallé; Donald E McMillan; Elizabeth M Laurenzana; Kelly A Byrnes-Blake; S Michael Owens
Journal:  Pharmacol Biochem Behav       Date:  2007-01-09       Impact factor: 3.533

4.  Towards a better understanding of the psychopharmacology of nutmeg: Activities in the mouse tetrad assay.

Authors:  Abir T El-Alfy; Lisa Wilson; Mahmoud A ElSohly; Ehab A Abourashed
Journal:  J Ethnopharmacol       Date:  2009-08-22       Impact factor: 4.360

5.  Evaluation of TLR4 Inhibitor, T5342126, in Modulation of Ethanol-Drinking Behavior in Alcohol-Dependent Mice.

Authors:  M Bajo; S E Montgomery; L N Cates; T Nadav; A M Delucchi; K Cheng; H Yin; E F Crawford; A J Roberts; M Roberto
Journal:  Alcohol Alcohol       Date:  2016-05-05       Impact factor: 2.826

Review 6.  Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applications.

Authors:  Eric C Peterson; W Brooks Gentry; S Michael Owens
Journal:  Adv Pharmacol       Date:  2014

Review 7.  Methamphetamine and the expanding complications of amphetamines.

Authors:  T E Albertson; R W Derlet; B E Van Hoozen
Journal:  West J Med       Date:  1999-04

8.  Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits.

Authors:  N P Pedersen; W W Blessing
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 9.  Development of active and passive human vaccines to treat methamphetamine addiction.

Authors:  W Brooks Gentry; Daniela Rüedi-Bettschen; S Michael Owens
Journal:  Hum Vaccin       Date:  2009-04-20

Review 10.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.